X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA ELDER PHARMA PLETHICO PHARMA/
ELDER PHARMA
 
P/E (TTM) x -1.1 -0.2 - View Chart
P/BV x 0.0 0.1 16.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ELDER PHARMA
Jun-14
PLETHICO PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs395380 103.9%   
Low Rs31188 16.6%   
Sales per share (Unadj.) Rs604.4491.2 123.0%  
Earnings per share (Unadj.) Rs32.5-3.2 -1,020.8%  
Cash flow per share (Unadj.) Rs51.314.4 356.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.6376.5 125.8%  
Shares outstanding (eoy) m34.0820.54 165.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.40.6 61.0%   
Avg P/E ratio x6.6-89.3 -7.4%  
P/CF ratio (eoy) x4.219.7 21.1%  
Price / Book Value ratio x0.50.8 59.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2625,833 124.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,5962,179 73.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m20,59810,089 204.2%  
Other income Rs m386257 150.6%   
Total revenues Rs m20,98410,346 202.8%   
Gross profit Rs m2,818-792 -355.8%  
Depreciation Rs m642361 177.8%   
Interest Rs m1,5932,756 57.8%   
Profit before tax Rs m969-3,653 -26.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m-138125 -110.6%   
Profit after tax Rs m1,107-65 -1,693.8%  
Gross profit margin %13.7-7.8 -174.3%  
Effective tax rate %-14.3-3.4 417.0%   
Net profit margin %5.4-0.6 -829.6%  
BALANCE SHEET DATA
Current assets Rs m18,8779,240 204.3%   
Current liabilities Rs m11,8969,998 119.0%   
Net working cap to sales %33.9-7.5 -451.3%  
Current ratio x1.60.9 171.7%  
Inventory Days Days3646 77.6%  
Debtors Days Days19860 330.0%  
Net fixed assets Rs m9,86110,124 97.4%   
Share capital Rs m341206 165.6%   
"Free" reserves Rs m12,3315,582 220.9%   
Net worth Rs m16,1397,734 208.7%   
Long term debt Rs m4,7064,889 96.3%   
Total assets Rs m33,14622,882 144.9%  
Interest coverage x1.6-0.3 -494.3%   
Debt to equity ratio x0.30.6 46.1%  
Sales to assets ratio x0.60.4 140.9%   
Return on assets %8.111.8 69.3%  
Return on equity %6.9-0.8 -811.6%  
Return on capital %12.322.3 55.1%  
Exports to sales %21.43.0 703.3%   
Imports to sales %15.20.4 3,563.9%   
Exports (fob) Rs m4,402307 1,435.9%   
Imports (cif) Rs m3,13643 7,276.1%   
Fx inflow Rs m4,402307 1,435.9%   
Fx outflow Rs m3,184125 2,541.0%   
Net fx Rs m1,219181 672.1%   
CASH FLOW
From Operations Rs m2,43711,754 20.7%  
From Investments Rs m-6,265-561 1,117.7%  
From Financial Activity Rs m2,490-6,762 -36.8%  
Net Cashflow Rs m-1,3374,432 -30.2%  

Share Holding

Indian Promoters % 82.7 39.6 208.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 7.5 57.3%  
FIIs % 5.5 16.8 32.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 36.1 20.8%  
Shareholders   10,665 16,479 64.7%  
Pledged promoter(s) holding % 85.7 77.6 110.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  ASTRAZENECA PHARMA  BIOCON LTD  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade in Green, Global Stock Markets, and Top Stocks in Action Today(Pre-Open)

Indian share markets continued their momentum yesterday and ended on a positive note. Gains were largely seen in the energy sector and PSU banking sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS